TISEO, GIUSY
 Distribuzione geografica
Continente #
NA - Nord America 1.924
AS - Asia 846
EU - Europa 786
SA - Sud America 231
AF - Africa 67
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.861
Nazione #
US - Stati Uniti d'America 1.896
SG - Singapore 306
CN - Cina 226
IT - Italia 224
BR - Brasile 206
HK - Hong Kong 198
SE - Svezia 189
DE - Germania 98
BG - Bulgaria 69
GB - Regno Unito 52
CI - Costa d'Avorio 37
RU - Federazione Russa 35
AT - Austria 33
IN - India 32
VN - Vietnam 28
FR - Francia 19
CA - Canada 17
CZ - Repubblica Ceca 17
FI - Finlandia 16
SN - Senegal 16
TR - Turchia 12
AR - Argentina 9
MX - Messico 8
JP - Giappone 7
EC - Ecuador 6
AU - Australia 5
CH - Svizzera 4
CO - Colombia 4
EG - Egitto 4
IE - Irlanda 4
IQ - Iraq 4
JO - Giordania 4
PH - Filippine 4
PK - Pakistan 4
PL - Polonia 4
ZA - Sudafrica 4
BD - Bangladesh 3
LT - Lituania 3
MA - Marocco 3
SA - Arabia Saudita 3
UA - Ucraina 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BE - Belgio 2
DK - Danimarca 2
ES - Italia 2
GR - Grecia 2
KE - Kenya 2
KW - Kuwait 2
NL - Olanda 2
NP - Nepal 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
BB - Barbados 1
CL - Cile 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KR - Corea 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TT - Trinidad e Tobago 1
Totale 3.861
Città #
Santa Clara 257
Chandler 209
Hong Kong 198
Ashburn 175
Fairfield 157
Singapore 149
Shanghai 117
New York 78
Seattle 74
Woodbridge 71
Sofia 68
Florence 61
Wilmington 61
Boardman 53
Houston 52
Princeton 50
Cambridge 47
Lawrence 42
Abidjan 37
Vienna 32
London 31
Medford 31
Munich 28
Ogden 25
Boulder 24
Frankfurt am Main 24
Los Angeles 21
Pisa 20
Ann Arbor 17
Dakar 16
Turku 15
Beijing 14
Brno 14
Pune 14
Serra 14
Bremen 13
Dallas 13
Nuremberg 13
Stockholm 12
Rome 11
San Diego 11
Belo Horizonte 10
Kent 10
Ottawa 10
Düsseldorf 9
Istanbul 9
Milan 9
Chicago 8
Dong Ket 8
Fuzhou 8
Redwood City 8
Brooklyn 7
São Paulo 7
Tokyo 7
Buffalo 6
Des Moines 6
Falls Church 6
Hefei 6
Rio de Janeiro 6
Brasília 5
Castelfranci 5
Hyderabad 5
Amman 4
Cairo 4
Cedar Knolls 4
Charlotte 4
Chennai 4
Dublin 4
Hebei 4
Lucca 4
Nanchang 4
Norwalk 4
Pontedera 4
Quito 4
Salt Lake City 4
Shenzhen 4
Toronto 4
Aracaju 3
Bern 3
Bexley 3
Campinas 3
Cascina 3
Catania 3
Cincinnati 3
Curitiba 3
Denver 3
Phoenix 3
San Francisco 3
Sydney 3
The Dalles 3
Urgnano 3
Xiamen 3
Ancona 2
Athens 2
Baghdad 2
Baku 2
Betim 2
Brdo 2
Brussels 2
Caxias do Sul 2
Totale 2.645
Nome #
C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study 143
Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-Negative infections in ICU patients 133
Corticosteroid Use and Incident Myocardial Infarction in Adults Hospitalized for Community-acquired Pneumonia 124
Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter SEI cohort 112
Antimicrobial consumption and impact of antimicrobial stewardship programmes in long-term care facilities 112
Impact of Initial Antifungal Therapy on the Outcome of Patients With Candidemia and Septic Shock Admitted to Medical Wards: A Propensity Score-Adjusted Analysis 104
Updates in the epidemiology and management of candidemia and Clostridioides difficile coinfection 102
Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19 101
Early alert from the microbiology laboratory improves the outcome of elderly patients with Enterococcus spp. bloodstream infection: Results from a multicentre prospective study 98
Identifying patients with acute bacterial skin and skin structure infection who need blood cultures 91
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae 90
Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19 90
Early Intra-Abdominal Bacterial Infections after Orthotopic Liver Transplantation: A Narrative Review for Clinicians 86
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality 84
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients 83
Clinical features and outcomes of bloodstream infections caused by New Delhi metallo-β-lactamase-producing enterobacterales during a regional outbreak 81
Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020 77
null 75
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii 75
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center 74
Comparison of Thrombotic Events and Mortality in Patients with Community-Acquired Pneumonia and COVID-19: A Multicenter Observational Study 74
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 73
Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19 73
Predicting resistant etiology in hospitalized patients with blood cultures positive for Gram-negative bacilli 72
Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes 72
Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: An observational study from Italy, 2020-21 72
Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study 71
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients with COVID-19 Pneumonia: A Randomized Clinical Trial 71
Cefiderocol for the treatment of metallo-beta-lactamases producing Gram negative bacilli: lights and shadows from the literature 70
Elevated MICs of susceptible antipseudomonal cephalosporins in non-carbapenemase-producing, carbapenem-resistant pseudomonas aeruginosa: Implications for dose optimization 68
Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy 67
Considerations for the optimal management of antibiotic therapy in elderly patients 66
Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern 66
Interplay between Nox2 Activity and Platelet Activation in Patients with Sepsis and Septic Shock: A Prospective Study 64
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 64
Caring for older adults during the COVID-19 pandemic 64
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience 62
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 62
Predictors and outcomes of respiratory bacterial coinfections in patients with COVID-19 admitted to hospital: An observational prospective study 61
Management of COVID patients with convalescent plasma: Do we have the final word? 61
Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios 57
Covid-19 early after renal transplantation: limitations and hazards of unproven therapies. Abstracts of the 20th Biennial European Society for Organ Transplantation (ESOT) Congress 53
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study) 50
Interpreting procalcitonin in patients undergoing hemodialysis: a reliable or a misleading marker? 50
Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study 50
Characteristics of long-COVID among older adults: a cross-sectional study 48
Prevention of the spread of multidrug-resistant organisms in nursing homes 46
What have we learned from the first to the second wave of COVID-19 pandemic? An international survey from the ESCMID Study Group for Infection in the Elderly (ESGIE) group 46
Characteristics of long COVID among older adults: a cross-sectional study 39
Recrudescence of Plasmodium falciparum malaria 5 years after treatment in an HIV migrant: a case report with a peculiar presentation 37
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 36
Effectiveness and safety of colistin among older adults: a systematic review and meta-analysis 32
Recurrent Clostridioides difficile infections in solid organ transplant recipients: The international CALIPSO study 26
Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score 25
Reply to Epling and Powers, "Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients" 24
Fatal disseminated Mycobacterium avium infection with bone marrow infiltration and hemophagocytic syndrome 21
Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by MBL- producing Enterobacterales 20
Impact of Fluconazole Resistance on the Outcomes of Patients With Candida parapsilosis Bloodstream Infections: A Retrospective Multicenter Study 14
Totale 3.962
Categoria #
all - tutte 16.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.111


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/2021280 10 6 5 8 10 14 71 29 38 20 35 34
2021/2022385 11 10 5 6 54 51 44 20 21 13 52 98
2022/2023792 76 84 72 74 76 103 11 63 148 2 76 7
2023/2024429 28 25 48 14 48 91 25 11 12 6 60 61
2024/20251.734 23 72 18 114 168 220 146 69 205 216 227 256
Totale 3.962